Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution
From MaRDI portal
Publication:6560575
DOI10.1002/sim.9935zbMath1540.62184MaRDI QIDQ6560575
Bethany J. Wolf, Virginia B. Shipes, Caitlyn Meinzer, Mathew J. Carpenter, Hooman Kamel, Renee' H. Martin, Hong Li
Publication date: 23 June 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
This page was built for publication: Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution